Letrozole Teva (Letrozole)

Letrozole blocks the aromatase enzyme, preventing the conversion of androgens to estrogen. This reduction in circulating estrogen limits the growth stimulus for estrogen‑dependent breast cancer cells, helping to control tumor progression.

The specific dose and regimen of letrozole are determined by the prescribing clinician based on the patient’s condition, treatment goals, and clinical guidelines. Patients should follow the prescriber’s instructions precisely.

Letrozole is contraindicated in pregnancy and is not recommended for use while breastfeeding because it can affect fetal and infant hormone development. Women of childbearing potential should use effective contraception during treatment.

To request Letrozole Teva, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Letrozole is a third‑generation aromatase inhibitor with high potency and a long half‑life, offering consistent estrogen suppression. Compared with anastrozole or exemestane, letrozole often shows slightly greater reductions in estrogen levels, though clinical choice depends on individual patient factors and tolerability.

Letrozole Teva should be stored at room temperature below 25 °C, in the original packaging, protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources.

Letrozole Teva is taken orally, usually once daily, with or without food, as directed by the healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless instructed otherwise.

Serious risks include severe liver injury, bone fractures due to decreased estrogen, and rare thromboembolic events such as pulmonary embolism. Patients should be monitored regularly for liver function, bone health, and signs of clotting disorders.

Letrozole should not be used by individuals with known hypersensitivity to the drug or its excipients, premenopausal women not receiving ovarian suppression, pregnant or breastfeeding women, and patients with severe liver impairment without appropriate medical supervision.